secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK:        0000882796
Form:       8-K
Filed at:   2025-12-11T23:59:59+00:00
Accession:  0001171843-25-007878
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

BioCryst board chair Nancy Hutson to retire; Vincent Milano named successor
---------------------------------------------------------------------------

- Nancy J. Hutson notified retirement from BioCryst board, effective earlier of Astria acquisition close or 2026 annual meeting.
- Hutson to continue as Chair and committee member until Retirement Date; cited no disagreement with board or management.
- Vincent J. Milano elected as next Board Chair, effective on Hutson's Retirement Date.
- Hutson served 14 years on the BioCryst board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882796/000117184325007878/0001171843-25-007878-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882796/000117184325007878/f8k_121125.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-007878

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer